Search Results for: APP

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
PGM3 phosphoglucomutase 3
  • Synthesis of UDP-N-acetyl-glucosamine
PHACTR4 phosphatase and actin regulator 4
PHAF1 phagophore assembly factor 1
PHF20L1 PHD finger protein 20 like 1
  • Formation of WDR5-containing histone-modifying complexes
PHF7 PHD finger protein 7
PHF8 PHD finger protein 8
  • HDMs demethylate histones
  • Syndromic X-linked mental retardation, including: Turner type (MRXST); Siderius type (MRXSSD) ; Cabezas type (MRXC); Raymond type (MRXSR); Type10 (MRXS10); Type14 (MRXS14); Mental retardation with isolated growth hormone deficiency (MRGH)
PHGDH phosphoglycerate dehydrogenase
  • Serine metabolism
  • NADH
PHLDA1 pleckstrin homology like domain family A member 1
  • Interaction between PHLDA1 and AURKA
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
PHLDA3 pleckstrin homology like domain family A member 3
PHYH phytanoyl-CoA 2-hydroxylase
  • Alpha-oxidation of phytanate
  • Peroxisomal protein import
  • Peroxisomal protein import
  • TYSND1 cleaves peroxisomal proteins
  • Antihemophilic factor, human recombinant
  • Ascorbic acid
  • Lonoctocog alfa
  • Moroctocog alfa
  • Refsum disease; Heredopathia atactica polyneuritiformis
PHYHD1 phytanoyl-CoA dioxygenase domain containing 1
PI4K2A phosphatidylinositol 4-kinase type 2 alpha
  • Synthesis of PIPs at the plasma membrane
  • Synthesis of PIPs at the Golgi membrane
  • Synthesis of PIPs at the early endosome membrane
PIBF1 progesterone immunomodulatory binding factor 1
PIGG phosphatidylinositol glycan anchor biosynthesis class G (EMM blood group)
  • Synthesis of glycosylphosphatidylinositol (GPI)
PIGO phosphatidylinositol glycan anchor biosynthesis class O
  • Synthesis of glycosylphosphatidylinositol (GPI)
PIK3R2 phosphoinositide-3-kinase regulatory subunit 2
  • PI3K Cascade
  • IRS-mediated signalling
  • GPVI-mediated activation cascade
  • PIP3 activates AKT signaling
  • Interleukin-7 signaling
  • Interleukin-7 signaling
  • Signaling by SCF-KIT
  • Synthesis of PIPs at the plasma membrane
  • Downstream signal transduction
  • PI3K/AKT activation
  • Signaling by ALK
  • Downstream TCR signaling
  • Role of phospholipids in phagocytosis
  • Tie2 Signaling
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • DAP12 signaling
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Nephrin family interactions
  • CD28 dependent PI3K/Akt signaling
  • G alpha (q) signalling events
  • VEGFA-VEGFR2 Pathway
  • VEGFA-VEGFR2 Pathway
  • Interleukin-3, Interleukin-5 and GM-CSF signaling
  • RAF/MAP kinase cascade
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • RET signaling
  • RHOA GTPase cycle
  • Extra-nuclear estrogen signaling
  • RHOB GTPase cycle
  • CDC42 GTPase cycle
  • RAC1 GTPase cycle
  • RAC2 GTPase cycle
  • RHOD GTPase cycle
  • RHOJ GTPase cycle
  • RHOU GTPase cycle
  • RAC3 GTPase cycle
  • RHOF GTPase cycle
  • Interleukin receptor SHC signaling
  • Regulation of signaling by CBL
  • Regulation of signaling by CBL
  • Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants
  • Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
  • Signaling by PDGFRA extracellular domain mutants
  • RND3 GTPase cycle
  • RND2 GTPase cycle
  • RND1 GTPase cycle
  • Signaling by ALK fusions and activated point mutants
  • Signaling by LTK in cancer
  • Signaling by LTK
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
  • Co-stimulation by ICOS
  • SF1126
PIK3R5 phosphoinositide-3-kinase regulatory subunit 5
  • GPVI-mediated activation cascade
  • PIP3 activates AKT signaling
  • Synthesis of PIPs at the plasma membrane
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • CD28 dependent PI3K/Akt signaling
  • G beta:gamma signalling through PI3Kgamma
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Co-stimulation by ICOS
PIKFYVE phosphoinositide kinase, FYVE-type zinc finger containing
  • Synthesis of PIPs at the Golgi membrane
  • Synthesis of PIPs at the Golgi membrane
  • Synthesis of PIPs at the early endosome membrane
  • Synthesis of PIPs at the early endosome membrane
  • Synthesis of PIPs at the late endosome membrane
  • Synthesis of PIPs at the late endosome membrane
  • Fleck corneal dystrophy (FCD); Francois-Neetens speckled corneal dystrophy
PIM1 Pim-1 proto-oncogene, serine/threonine kinase
  • Interleukin-4 and Interleukin-13 signaling
  • STAT5 activation downstream of FLT3 ITD mutants
  • Signaling by FLT3 fusion proteins
  • 3,4-Dihydroxy-1-Methylquinolin-2(1h)-One
  • Staurosporine
  • LY-294002
  • Imidazole
  • (3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One
  • Bisindolylmaleimide I
  • Quercetin
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • Dexfosfoserine
  • S,S-(2-Hydroxyethyl)Thiocysteine
  • IMIDAZOPYRIDAZIN 1
  • 4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one
  • (4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile
  • N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine
  • (2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile
  • (4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile
  • Tricetin
  • 6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE
  • 4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine
  • N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine
  • 2,3-diphenyl-1H-indole-7-carboxylic acid
  • Fostamatinib
PIMREG PICALM interacting mitotic regulator

Page 67 out of 106 pages